维普中文期刊产品整合服务
11篇 您的检索式:作者名="Gerard AS"
    题名 作者 年代 出处 被引量
1Glibenclamide pharmacokinetics in acarbose-treated type 2 diabetics显示文摘Gerard J Lefebvre PJ Luyckx AS 1984Eur J Clin Pharmacol1984,27,2:1
2Diagnosis and successful medical treatment of Acanthamoeba keratitis显示文摘Gerard DA George AS William TD 1995Arch Ophthalmol1995,113,10:1
3SATB2 Is a Multifunctional Determinant of Craniofacial Patterning and Osteoblast Differentiation显示文摘Gergana Dobreva Maria Chahrour Marcel Dautzenberg Laura Chirivella Benoit Kanzler Isabel Fari?as Gerard Karsenty Rudolf Grosschedl 2006Cell2006,,5:1
4Early maturation of gonadotropin - re- leasing hormone secretion and sexual precocity after exposure of infant female rats to estradiol or dichlorodiphenyltrichloroethane 显示文摘Rasier G Parent AS Gerard A 2007Biol Re- prod2007,77,4:1
5Early onset of puberty: tracking genetic and environmental factors 显示文摘Parent AS Rasier G Gerard A 2005Horm Res2005,64,2:1
6Experimental verification and the- oretical prediction of cartilage intersitial pressurization at an impermeable contact interface in confined compression 显示文摘Michael AS Gerard AA 1998J Biomech1998,31,10:1
7One hundred years of lung cancer显示文摘Stephen GS Gerard AS 2005Am J Respir Cri Care Med2005,172,:1
8Early onset of puberty:tracking genetic and environmental factors显示文摘Parent AS Rasier G Gerard A 2005Horm Res2005,64,:1
9Early onset of puberty:tracking genetic and environmental factors显示文摘Parent AS Rasier G Gerard A 0,,02:1
10Screening for lung cancer显示文摘James GR Philip C Gerard AS 2008Am J Roentgenol2008,190,:1
11Conservation and variability of hepatitis B core at different chronic hepatitis stages显示文摘BACKGROUND Since it is currently not possible to eradicate hepatitis B virus(HBV)infection with existing treatments,research continues to uncover new therapeutic strategies.HBV core protein,encoded by the HBV core gene(HBC),intervenes in both structural and functional processes,and is a key protein in the HBV life cycle.For this reason,both the protein and the gene could be valuable targets for new therapeutic and diagnostic strategies.Moreover,alterations in the protein sequence could serve as potential markers of disease progression.AIM To detect,by next-generation sequencing,HBC hyper-conserved regions that could potentially be prognostic factors and targets for new therapies.METHODS Thirty-eight of 45 patients with chronic HBV initially selected were included and grouped according to liver disease stage[chronic hepatitis B infection without liver damage(CHB,n=16),liver cirrhosis(LC,n=5),and hepatocellular carcinoma(HCC,n=17)].HBV DNA was extracted from patients’plasma.A region between nucleotide(nt)1863 and 2483,which includes HBC,was amplified and analyzed by next-generation sequencing(Illumina Mi Seq platform).Sequences were genotyped by distance-based discriminant analysis.General and intergroup nt and amino acid(aa)conservation was determined by sliding window analysis.The presence of nt insertion and deletions and/or aa substitutions in the different groups was determined by aligning the sequences with genotype-specific consensus sequences.RESULTS Three nt(nt 1900-1929,2249-2284,2364-2398)and 2 aa(aa 117-120,159-167)hyper-conserved regions were shared by all the clinical groups.All groups showed a similar pattern of conservation,except for five nt regions(nt 1946-1992,2060-2095,2145-2175,2230-2250,2270-2293)and one aa region(aa 140-160),where CHB and LC,respectively,were less conserved(P<0.05).Some group-specific conserved regions were also observed at both nt(2306-2334 in CHB and 1935-1976 and 2402-2435 in LC)and aa(between aa 98-103 in CHB and 28-30 and 51-54 in LC)levels.No differences in insertion and deletions frequencies were observed.An aa substitution(P79 Q)was observed in the HCC group with a median(interquartile range)frequency of 15.82(0-78.88)vs 0(0-0)in the other groups(P<0.05 vs CHB group).CONCLUSION The differentially conserved HBC and HBV core protein regions and the P79 Q substitution could be involved in disease progression.The hyper-conserved regions detected could be targets for future therapeutic and diagnostic strategies.Marcal Yll Maria Francesca Cortese Mercedes Guerrero-Murillo Gerard Orriols Josep Gregori Rosario Casillas Carolina González Sara Sopena Cristina Godoy Marta Vila David Tabernero Josep Quer Ariadna Rando Rosa Lopez-Martinez Rafael Esteban Mar Riveiro-Barciela Maria Buti Francisco Rodríguez-Frías 2020World Journal of Gastroenterology2020,26,20:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费